Published in Prog Retin Eye Res on November 01, 2001
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet (2006) 8.33
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A (2002) 6.47
Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet (2005) 4.91
Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med (2008) 3.92
The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol (2006) 3.60
The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res (2009) 3.40
CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest (2007) 3.39
Molecular pathology of age-related macular degeneration. Prog Retin Eye Res (2008) 3.35
Age-related macular degeneration. Lancet (2008) 3.34
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet (2005) 3.19
Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Ann Med (2006) 2.99
Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet (2004) 2.97
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet (2005) 2.92
Vascular endothelial growth factor in eye disease. Prog Retin Eye Res (2008) 2.73
Mechanisms of age-related macular degeneration. Neuron (2012) 2.62
Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci U S A (2006) 2.45
Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2006) 2.40
Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet (2009) 2.40
Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med (2012) 2.37
Systemic complement activation in age-related macular degeneration. PLoS One (2008) 2.18
Genetic factors of age-related macular degeneration. Prog Retin Eye Res (2004) 2.17
Immunology of age-related macular degeneration. Nat Rev Immunol (2013) 2.14
CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med (2005) 2.01
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol (2007) 2.00
Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am J Pathol (2005) 1.92
Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci (2009) 1.86
Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol (2003) 1.85
The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci (2009) 1.84
Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology (2008) 1.83
Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog Retin Eye Res (2009) 1.80
Spectral domain optical coherence tomography imaging of geographic atrophy margins. Ophthalmology (2009) 1.80
Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res (2010) 1.79
Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration. Invest Ophthalmol Vis Sci (2006) 1.70
Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci (2008) 1.70
Drusen characterization with multimodal imaging. Retina (2010) 1.70
Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet (2014) 1.69
Therapeutic targets in age-related macular disease. J Clin Invest (2010) 1.68
The oil spill in ageing Bruch membrane. Br J Ophthalmol (2011) 1.62
Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A (2007) 1.62
Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology (2009) 1.62
mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. J Clin Invest (2010) 1.61
NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest Ophthalmol Vis Sci (2013) 1.58
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.56
Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci (2008) 1.55
No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese. Hum Genet (2006) 1.54
A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.54
Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc Natl Acad Sci U S A (2005) 1.54
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov (2012) 1.52
The epidemiology of retinal reticular drusen. Am J Ophthalmol (2007) 1.50
Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci (2008) 1.47
Complement activation by bisretinoid constituents of RPE lipofuscin. Invest Ophthalmol Vis Sci (2008) 1.47
Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med (2012) 1.46
Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury. J Biol Chem (2009) 1.45
Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp Eye Res (2007) 1.45
The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS One (2008) 1.44
Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest (2006) 1.43
Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol (2010) 1.42
Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab (2013) 1.42
Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res (2009) 1.41
Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics (2009) 1.39
Complement in age-related macular degeneration: a focus on function. Eye (Lond) (2011) 1.39
Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe. Biochem J (2008) 1.36
Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem (2010) 1.36
Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care (2008) 1.35
Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. Ophthalmology (2013) 1.35
Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration. Autophagy (2013) 1.34
Choroideremia: new findings from ocular pathology and review of recent literature. Surv Ophthalmol (2009) 1.34
The pathogenic role of the canonical Wnt pathway in age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.31
Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.30
Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.30
Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology (2010) 1.29
The association between statin use and age related maculopathy. Br J Ophthalmol (2003) 1.28
Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. Invest Ophthalmol Vis Sci (2008) 1.28
Spare the rod and spoil the eye. Br J Ophthalmol (2005) 1.28
Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy. Exp Eye Res (2011) 1.25
Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment. Indian J Ophthalmol (2009) 1.24
Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci (2008) 1.24
Age-related macular degeneration: genetic and environmental factors of disease. Mol Interv (2010) 1.24
Inflammatory cytokines regulate microRNA-155 expression in human retinal pigment epithelial cells by activating JAK/STAT pathway. Biochem Biophys Res Commun (2010) 1.23
C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS One (2008) 1.22
A2E induces IL-1ß production in retinal pigment epithelial cells via the NLRP3 inflammasome. PLoS One (2013) 1.22
Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. Ophthalmology (2008) 1.22
Improved contrast of subretinal structures using polarization analysis. Invest Ophthalmol Vis Sci (2003) 1.21
Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation). Mediators Inflamm (2014) 1.20
Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration. Exp Eye Res (2008) 1.19
Age and disease-related structural changes in the retinal pigment epithelium. Clin Ophthalmol (2008) 1.19
CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuroinflammation (2010) 1.18
The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2011) 1.18
Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci (2009) 1.18
Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. Invest Ophthalmol Vis Sci (2013) 1.17
Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol (2014) 1.17
Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. Prog Retin Eye Res (2014) 1.17
Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol (2011) 1.16
Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1β, tumor necrosis factor-α, and interferon-γ. Mol Vis (2013) 1.16
Genetics. Was the Human Genome Project worth the effort? Science (2005) 1.16
The role of the immune response in age-related macular degeneration. Int J Inflam (2013) 1.16
Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci U S A (1980) 7.31
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res (2001) 4.38
Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J Cell Biol (1981) 3.97
Corticobasal degeneration. Brain (1989) 3.20
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res (1991) 2.71
A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res (2000) 2.58
Disc morphogenesis in vertebrate photoreceptors. J Comp Neurol (1980) 2.57
Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet (2001) 2.48
Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol (2000) 2.27
Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci U S A (1993) 2.15
Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J (1999) 2.00
Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci U S A (2005) 1.92
Renewal of the terminal bronchiolar epithelium in the rat following exposure to NO2 or O3. Lab Invest (1976) 1.85
Morphological recovery in the reattached retina. Invest Ophthalmol Vis Sci (1986) 1.79
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol (2001) 1.64
Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci (1989) 1.63
Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A (2006) 1.63
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. Tuberculosis (Edinb) (2003) 1.55
Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci (1995) 1.55
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
Laccase-mediated detoxification of phenolic compounds. Appl Environ Microbiol (1988) 1.55
Specific binding of peanut lectin to a class of retinal photoreceptor cells. A species comparison. Invest Ophthalmol Vis Sci (1984) 1.53
Selective lectin binding of the developing mouse retina. J Comp Neurol (1983) 1.52
Mammalian cones: disc shedding, phagocytosis, and renewal. Invest Ophthalmol Vis Sci (1978) 1.50
The interphotoreceptor matrix mediates primate retinal adhesion. Arch Ophthalmol (1995) 1.49
Probing mitochondria in living cells with rhodamine 123. Cold Spring Harb Symp Quant Biol (1982) 1.46
Retinal detachment in the cat: the outer nuclear and outer plexiform layers. Invest Ophthalmol Vis Sci (1983) 1.45
Crystal structure of alpha 1: implications for protein design. Science (1990) 1.44
Complete sequence and organization of the human cardiac beta-myosin heavy chain gene. Nucleic Acids Res (1990) 1.42
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). Exp Eye Res (2007) 1.35
Retinal detachment in the cat: the pigment epithelial-photoreceptor interface. Invest Ophthalmol Vis Sci (1983) 1.33
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Molecular composition of drusen as related to substructural phenotype. Mol Vis (1999) 1.28
Application of acrylamide as an embedding medium in studies of lectin and antibody binding in the vertebrate retina. Curr Eye Res (1984) 1.26
The onset of pigment epithelial proliferation after retinal detachment. Invest Ophthalmol Vis Sci (1981) 1.26
Characterization of drusen-associated glycoconjugates. Ophthalmology (1997) 1.25
Hormonal influences on brain organization in infant rats. Science (1966) 1.24
Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci (1991) 1.21
Vitronectin receptor expression and distribution at the photoreceptor-retinal pigment epithelial interface. J Comp Neurol (1995) 1.21
Anomie and alcohol use. Drinking patterns in Mexican American and Anglo neighborhoods. J Stud Alcohol (1978) 1.20
Glial fibrillary acidic protein increases in Müller cells after retinal detachment. Exp Eye Res (1987) 1.17
Transmembrane assemblage of the photoreceptor connecting cilium and motile cilium transition zone contain a common immunologic epitope. Cell Motil Cytoskeleton (1990) 1.17
Molecular cloning and expression of a MAP kinase homologue from pea. Plant Mol Biol (1993) 1.15
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol (1998) 1.14
Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci (1999) 1.14
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
Rapid changes in the expression of glial cell proteins caused by experimental retinal detachment. Am J Ophthalmol (1994) 1.13
Centrosymmetric bilayers in the 0.75 A resolution structure of a designed alpha-helical peptide, D,L-Alpha-1. Protein Sci (1999) 1.11
Interphotoreceptor matrix domains ensheath vertebrate cone photoreceptor cells. Invest Ophthalmol Vis Sci (1986) 1.10
Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res (1994) 1.10
The relationship of primate foveal cones to the pigment epithelium. J Ultrastruct Res (1979) 1.10
Vascular atrophy in the retinal degenerative rd mouse. J Comp Neurol (1986) 1.10
Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09
The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci (1999) 1.09
Pulmonary lesions due to opportunist mycobacteria. (Review includes 30 cases of M. kansasii infections). Clin Radiol (1975) 1.06
Macrophages in neovascular age-related macular degeneration: friends or foes? Eye (Lond) (2008) 1.05
Changes in the expression of specific Müller cell proteins during long-term retinal detachment. Exp Eye Res (1989) 1.05
Recovery of photoreceptor outer segment length and analysis of membrane assembly rates in regenerating primate photoreceptor outer segments. Invest Ophthalmol Vis Sci (1993) 1.04
Predicting the pathogenicity of RPE65 mutations. Hum Mutat (2009) 1.01
A cooperative model for receptor recognition and cell adhesion: evidence from the molecular packing in the 1.6-A crystal structure of the pheromone Er-1 from the ciliated protozoan Euplotes raikovi. Proc Natl Acad Sci U S A (1995) 1.01
Rod and cone disc shedding in the rhesus monkey retina: a quantitative study. Exp Eye Res (1980) 1.00
TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (2000) 0.99
Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett (1992) 0.99
Both rod and cone disc shedding are related to light onset in the cat. Invest Ophthalmol Vis Sci (1983) 0.98
Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol (2000) 0.98
Use of the MIB-1 antibody for detecting proliferating cells in the retina. Invest Ophthalmol Vis Sci (1995) 0.97
Decreased uptake and retention of rhodamine 123 by mitochondria in feline sarcoma virus-transformed mink cells. Cell (1982) 0.97
Basic fibroblast growth factor: a potential regulator of proliferation and intermediate filament expression in the retina. J Neurosci (1992) 0.97
Cell renewal in the lungs of rats exposed to low levels of ozone. Exp Mol Pathol (1976) 0.96
Crystal structure of phospholipase A2 from Indian cobra reveals a trimeric association. Proc Natl Acad Sci U S A (1993) 0.96
Correlation of MRI and neuropathology in AIDS. J Neurol Neurosurg Psychiatry (1997) 0.96
Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix. Proc Natl Acad Sci U S A (1991) 0.94
Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Biochem J (1991) 0.94
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2008) 0.93
A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. Neurology (1996) 0.93
The photoreceptors of diurnal squirrels: outer segment structure, disc shedding, and protein renewal. J Ultrastruct Res (1976) 0.93
Neurotrophic activity of interphotoreceptor matrix on human Y79 retinoblastoma cells. J Comp Neurol (1992) 0.93
Biochemical characterization of the major peanut-agglutinin-binding glycoproteins in vertebrate retinae. J Comp Neurol (1986) 0.91
Disc shedding in rodlike and conelike photoreceptors of tree squirrels. Science (1975) 0.89
Packed protein bilayers in the 0.90 A resolution structure of a designed alpha helical bundle. Protein Sci (1999) 0.89
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus. Vision Res (2002) 0.89
Changes in intermediate filament immunolabeling occur in response to retinal detachment and reattachment in primates. Invest Ophthalmol Vis Sci (1990) 0.89
Vitronectin gene expression in the adult human retina. Invest Ophthalmol Vis Sci (1999) 0.89
Scotopic and photopic vision in the California ground squirrel: physiological and anatomical evidence. J Comp Neurol (1976) 0.89
Ocular toxicity of fluorouracil after vitrectomy. Am J Ophthalmol (1983) 0.89
Selective sequestration of an oviductal fluid glycoprotein in the perivitelline space of mouse oocytes and embryos. J Exp Zool (1986) 0.89
Expression of the glaucoma gene myocilin (MYOC) in the human optic nerve head. FASEB J (2001) 0.89
Stage-specific binding of peanut agglutinin to aggregates of degenerating photoreceptor cells in the rd mouse retina. Exp Eye Res (1993) 0.89
Norrie disease and peripheral venous insufficiency. Br J Ophthalmol (2004) 0.89